Genmab A (GMAB) Interest Coverage Ratio (2019 - 2026)
Genmab A (GMAB) reported Interest Coverage Ratio of 1.2 for Q1 2026, up 71.28% on a YoY basis from 0.7 in Q1 2025, and up 90.33% quarter-over-quarter from 12.41 in Q3 2025.
Genmab A (GMAB) Interest Coverage Ratio (2019 - 2026) Analysis & Trends
Genmab A has reported Interest Coverage Ratio for 5 years, with the latest figure at 1.2 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio rose 71.28% year-over-year to 1.2; the trailing twelve-month figure through Mar 2026 stood at 4.27 (up 3.55% YoY), and the FY2025 full-year result was 3.96, up 18.53% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 1.2, up from 12.41 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 1.2 in Q1 2026, with the low at 12.41 in Q3 2025.
- Historically, Interest Coverage Ratio has averaged 4.75 across 3 years, with a median of 3.96 in 2025.
- Annual changes were most pronounced in 2025 — Interest Coverage Ratio tumbled 304.18% — and 2026, when it surged 71.28%.
- Genmab A's Interest Coverage Ratio stood at 3.07 in 2024, then tumbled by 304.18% to 12.41 in 2025, then soared by 90.33% to 1.2 in 2026.
- The last three Interest Coverage Ratio figures came in at 1.2 (Q1 2026), 12.41 (Q3 2025), and 3.96 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -258.33 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 11.79 |
| 10 | Genmab A | 48.34 Bn | 46.82 Bn | 831.00 Mn | -1.20 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.20 |
| Sep 30, 2025 | -12.41 |
| Jun 30, 2025 | -3.96 |
| Mar 31, 2025 | -4.18 |
| Sep 30, 2024 | -3.07 |
| Jun 30, 2024 | -5.13 |
| Mar 31, 2024 | -3.31 |
| Sep 30, 2020 | -1,191.67 Bn |
| Dec 31, 2019 | -43.88 |